Skip to player
Skip to main content
Skip to footer
Search
Connect
Watch fullscreen
1
Bookmark
Share
Add to Playlist
Report
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
Benzinga
Follow
1 year ago
Eli Lilly has come out on top in a weight loss drug competition in a recent study. The study found that patients on Lilly’s Mounjaro lost more weight than those on Novo Nordisk’s Ozempic.
Category
🗞
News
Recommended
1:00
|
Up next
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Benzinga
1 year ago
1:19
Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
Benzinga
1 year ago
1:20
Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
Benzinga
11 months ago
1:04
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
1 year ago
0:43
Novo Tanks 25% on Surprise Demand Drop
Benzinga
5 weeks ago
3:04
How End Of Month Buy And Sell Imbalances Effected Stock Movements
Benzinga
2 years ago
4:17
Apple Stock Dips After KeyBanc Cuts Rating On iPhone Sale Concerns: What Investors Need To Know
Benzinga
10 months ago
4:07
Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
Benzinga
2 years ago
0:41
Ulta Beauty Stock Climbs On Q4 Earnings Beat: 'Fiscal 2025 Will Be A Pivotal Year'
Benzinga
6 months ago
4:15
Something Is Happening In The Utilities Sector That Investors Should Watch Out For | $XLU
Benzinga
11 months ago
1:45
Are Housing Stocks Pointing Towards A Recession? - $TOL
Benzinga
2 years ago
0:39
Two Top Executives Resign as Investigation Links Deaths to Kobayashi Pharmaceutical's Rice Products
Benzinga
1 year ago
2:34
Disaster Stock Of The Day: Why Dick's Sporting Goods Shares Are Diving Today $DKS
Benzinga
2 years ago
1:08
As Global Markets Roil, Strategist Soothes Nerves: 'Some Normal Action Under The Surface' As 'Tech Got Way Ahead Of Itself'
Benzinga
1 year ago
15:51
Dee Choubey, Co-Founder and CEO of MoneyLion - $ML
Benzinga
2 years ago
0:58
Charlie Munger Revealed What Was Left On His Bucket List Before He Died
Benzinga
2 years ago
0:31
GameStop Rockets As Roaring Kitty Returns To X: What Does His Tweet Signal Ahead Of Q3 Earnings?
Benzinga
9 months ago
7:13
From Meme to Market: Apu Apustaja's Journey to a $380M Market Cap
Benzinga
1 year ago
4:15
Go Woke, Go Broke, ETF and GUNZ ETF, Matthew Tuttle, Tuttle Capital Management
Benzinga
2 years ago
0:45
Vivek Ramaswamy Breathes New Life Into Beaten Down BuzzFeed Stock: What Investors Need To Know
Benzinga
1 year ago
2:08
Does The Dip In The S&P500 Indicate A New Downtrend Or Just A Pullback?
Benzinga
1 year ago
1:26
Lululemon's China Cooldown And US Struggles Weigh On Outlook
Benzinga
6 weeks ago
1:31
Why Is The Fed Still So Aggressive? - Jeremy Schwartz, Chief Investment Officer at WisdomTree
Benzinga
2 years ago
10:13
Super League Enterprise $SLE Unveils SOUNDZ: A Game-Changer For Brand & Artist Engagement On Roblox
Benzinga
1 year ago
0:52
Jim Cramer Reacts As UnitedHealth Denies Report On Criminal Probe—'If Convicted of Criminal Medicare Fraud…'
Benzinga
4 months ago